Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Organic Letters|July 7, 2011
Palladium-catalyzed cross-coupling of benzyl thioacetates and aryl halidesKrista M Wager, Matthew H DanielsOrganic Letters|July 9, 2016
Sequential Regioselective C-H Functionalization of ThiophenesMatthew H Daniels, Jeremy R Armand, Kian L TanJournal of Medicinal Chemistry|February 10, 2022
Discovery and Optimization of Highly Selective Inhibitors of CDK5Matthew H Daniels, Goran Malojcic, Susan L Clugston, et al.Journal of Medicinal Chemistry|March 3, 2018
The Discovery of ( S)-1-(6-(3-((4-(1-(Cyclopropanecarbonyl)piperidin-4-yl)-2-methylphenyl)amino)-2,3-dihydro-1 H-inden-4-yl)pyridin-2-yl)-5-methyl-1 H-pyrazole-4-carboxylic Acid, a Soluble Guanylate Cyclase Activator Specifically Designed for Topical Ocular Delivery as a Therapy for GlaucomaTakeru Ehara, Christopher M Adams, Doug Bevan, et al.Journal of Medicinal Chemistry|April 29, 2025
Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9Matthew H Daniels, Jennifer Castro, Young-Tae Lee, et al.Cancer Research|November 26, 2024
A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch RepairJennifer Castro, Matthew H Daniels, David Brennan, et al.Journal of Medicinal Chemistry|February 6, 2013
Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-MetAlan B Northrup, Matthew H Katcher, Michael D Altman, et al.Bioorganic & Medicinal Chemistry Letters|March 9, 2010
Purine derivatives as potent gamma-secretase modulatorsAlexey Rivkin, Sean P Ahearn, Stephanie M Chichetti, et al.Pageof 1